Corrigendum to "Safety and immunogenicity of mRNA-LNP COVID-19 vaccine CVnCoV in Latin American adults: A phase 2 randomized study" [Vaccine: X 11 (2022) 100189]
Description
[This corrects the article DOI: 10.1016/j.jvacx.2022.100189.].
